Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kühbacher

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Colorectal Disease|May 18, 2001
Pouchitis and the risk of cancer?T Kühbacher
Zeitschrift Fur Gastroenterologie|April 28, 2001
[Using colonoscopy in early detection of proximal neoplasia in asymptomatic patients]T Kühbacher, U R Fölsch
International Journal of Colorectal Disease|December 31, 1998
Pouchitis: pathophysiology and treatmentT Kühbacher, S Schreiber, N Runkel
Virchows Archiv : an International Journal of Pathology|March 21, 1998
Comparison of matrix metalloproteinase expression in normal and cirrhotic human liverR Lichtinghagen, K Breitenstein, B Arndt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 11, 2002
[Radiological assessment of small bowel obstructions: Value of conventional enteroclysis and dynamic MR-enteroclysis]A Rohr, D Rohr, T Kühbacher, et al.
The Pharmacogenomics Journal|June 7, 2002
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximabS Mascheretti, J Hampe, T Kühbacher, et al.
Clinical and Experimental Immunology|April 12, 2001
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitisT Kühbacher, P Gionchetti, J Hampe, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Gut|August 13, 2002
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseaseS Schreiber, P Rosenstiel, J Hampe, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitisF Bär, T Kühbacher, N A Dietrich, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Colorectal Disease|May 18, 2001
Pouchitis and the risk of cancer?T Kühbacher
Zeitschrift Fur Gastroenterologie|April 28, 2001
[Using colonoscopy in early detection of proximal neoplasia in asymptomatic patients]T Kühbacher, U R Fölsch
International Journal of Colorectal Disease|December 31, 1998
Pouchitis: pathophysiology and treatmentT Kühbacher, S Schreiber, N Runkel
Virchows Archiv : an International Journal of Pathology|March 21, 1998
Comparison of matrix metalloproteinase expression in normal and cirrhotic human liverR Lichtinghagen, K Breitenstein, B Arndt, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 11, 2002
[Radiological assessment of small bowel obstructions: Value of conventional enteroclysis and dynamic MR-enteroclysis]A Rohr, D Rohr, T Kühbacher, et al.
The Pharmacogenomics Journal|June 7, 2002
Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximabS Mascheretti, J Hampe, T Kühbacher, et al.
Clinical and Experimental Immunology|April 12, 2001
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitisT Kühbacher, P Gionchetti, J Hampe, et al.
Gut|June 13, 2003
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trialC S J Probert, S D Hearing, S Schreiber, et al.
Gut|August 13, 2002
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseaseS Schreiber, P Rosenstiel, J Hampe, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2017
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitisF Bär, T Kühbacher, N A Dietrich, et al.
Pageof 2